MwanzoBRNS • NASDAQ
add
Barinthus Biotherapeutics PLC - ADR
Bei iliyotangulia
$ 0.72
Bei za siku
$ 0.71 - $ 0.75
Bei za mwaka
$ 0.65 - $ 2.92
Thamani ya kampuni katika soko
29.14M USD
Wastani wa hisa zilizouzwa
elfu 71.51
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
NASDAQ
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | — | — |
Matumizi ya uendeshaji wa biashara | 5.00M | -62.68% |
Mapato halisi | -14.57M | -79.52% |
Kiwango cha faida halisi | — | — |
Mapato kwa kila hisa | -0.24 | -16.19% |
EBITDA | -10.12M | -16.58% |
Asilimia ya kodi ya mapato | 0.48% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 74.27M | -30.00% |
Jumla ya mali | 109.20M | -42.13% |
Jumla ya dhima | 24.64M | -15.70% |
Jumla ya hisa | 84.56M | — |
hisa zilizosalia | 40.83M | — |
Uwiano wa bei na thamani | 0.35 | — |
Faida inayotokana na mali | -21.41% | — |
Faida inayotokana mtaji | -24.28% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Sep 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -14.57M | -79.52% |
Pesa kutokana na shughuli | -10.73M | 41.06% |
Pesa kutokana na uwekezaji | elfu 451.00 | 495.61% |
Pesa kutokana na ufadhili | 0.00 | -100.00% |
Mabadiliko halisi ya pesa taslimu | -12.11M | -3.75% |
Mtiririko huru wa pesa | -6.18M | 66.42% |
Kuhusu
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
Ilianzishwa
2016
Tovuti
Wafanyakazi
105
